Cedarburg Hauser Pharmaceuticals Receives CMO Leadership Award in Productivity
GRAFTON, Wis., Aug. 8, 2013 /PRNewswire/ -- Cedarburg Hauser Pharmaceuticals (CHP), a contract development and manufacturing organization (CDMO), announces the receipt of a CMO Leadership Award for excellence in productivity. This is the second consecutive year CHP has received an award in this category.
"Receiving a CMO Leadership Award in productivity for a second consecutive year is a testament to our team," says Tony Laughrey, Chief Executive Officer of Cedarburg Hauser. "Productivity is vital to our success as it allows us to deliver on-time solutions to our customers," Laughrey continued. "At Cedarburg Hauser, productivity is ensured with a project management team that effectively brings together scientists and operational resources to meet and exceed our customer's expectations."
The CMO Leadership Awards are presented by Life Science Leader, based on research conducted by Nice Insight. The awards recognize companies ranked in the top 20 percent of their respective categories, and are based on a survey of over 10,000 pharmaceutical and biotechnology executives conducted by Nice Insight. More information on the award can be found at www.cmoleadershipawards.com.
About Cedarburg Hauser Pharmaceuticals
Cedarburg Hauser Pharmaceuticals is an experienced contract development and manufacturing organization (CDMO), specializing in small molecule active pharmaceutical ingredients (API) and pharmaceutical intermediates. Cedarburg Hauser leverages a talented group of scientists and supporting -staff, as well as a centralized approach to project management, to ensure on-time and on-budget completion of projects involving the development, scale-up, and manufacturing of complex APIs.
Read more news from Cedarburg Hauser Pharmaceuticals.
SOURCE Cedarburg Hauser Pharmaceuticals